10X Genomics Inc Class A (TXG)

Cost of Revenue

$184.88M

TTM · Period ending: · USD

TXG logo

TXG Cost of Revenue

Latest reported$184.88M
TXG TTM Cost of Revenue ($28.95M → $184.88M)
High-resolution chart · PNG

TXG cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

10X Genomics Inc Class A Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
184,884,000
194,169,000
198,942,000
200,023,000
196,589,000
197,649,000
196,303,000
210,434,000
223,288,000
221,611,000
209,414,000
178,044,000
150,306,000
130,803,000
120,386,000
111,157,000
105,298,000
82,509,000
74,091,000
65,390,000
55,283,000
60,420,000
58,468,000
56,153,000
57,222,000
62,176,000
61,033,000
59,351,000
49,112,000
38,656,000
28,951,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.